tradingkey.logo
tradingkey.logo
Search

Immunome Inc

IMNM
Add to Watchlist
22.760USD
-0.320-1.39%
Close 07-31 16:00ETQuotes delayed by 15 min
2.58BMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
10.00
Change
0
The current institutional shareholding score of Immunome Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 102.66%, representing a quarter-over-quarter increase of 21.95%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.06% of shares outstanding, with 1.32% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
16.54M
+26.67%
T. Rowe Price Investment Management, Inc.
13.42M
+26.09%
Point72 Asset Management, L.P.
Star Investors
7.03M
+45.82%
BlackRock Institutional Trust Company, N.A.
6.35M
+21.32%
Redmile Group, LLC
5.72M
+13.84%
PRIMECAP Management Company
Star Investors
4.69M
+55.25%
Enavate Sciences GP, LLC
4.77M
--
State Street Investment Management (US)
3.87M
+37.95%
Driehaus Capital Management, LLC
3.71M
+432.05%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.